Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a GVGH iNTS-TCV vaccine study in African infants
PACTR202507692744228Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Nov 2025
- Countries
- 1
01
Overview
Phase 2 trial in invasive non-typhoidal salmonellosis (iNTS) and typhoid fever (14 arms), sponsored by GSK. Planned start Nov 2025; status: not yet recruiting.
02
Conditions
invasive non-typhoidal salmonellosis (iNTS)typhoid fever
Beyond the preview
Go deeper on PACTR202507692744228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507692744228.